Brown Advisory Securities LLC raised its position in shares of Colgate-Palmolive Company (NYSE:CL) by 8.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 13,900 shares of the company’s stock after buying an additional 1,095 shares during the period. Brown Advisory Securities LLC’s holdings in Colgate-Palmolive were worth $1,016,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the stock. Confluence Investment Management LLC boosted its stake in shares of Colgate-Palmolive by 19.3% in the first quarter. Confluence Investment Management LLC now owns 1,271,035 shares of the company’s stock worth $93,027,000 after buying an additional 206,048 shares during the last quarter. West Oak Capital LLC boosted its stake in shares of Colgate-Palmolive by 13.8% in the first quarter. West Oak Capital LLC now owns 29,378 shares of the company’s stock worth $2,150,000 after buying an additional 3,573 shares during the last quarter. Trust Co boosted its stake in shares of Colgate-Palmolive by 2.4% in the fourth quarter. Trust Co now owns 21,856 shares of the company’s stock worth $1,430,000 after buying an additional 506 shares during the last quarter. Indiana Trust & Investment Management CO acquired a new stake in shares of Colgate-Palmolive during the first quarter worth about $218,000. Finally, Northstar Group Inc. boosted its stake in shares of Colgate-Palmolive by 0.4% in the first quarter. Northstar Group Inc. now owns 4,850 shares of the company’s stock worth $356,000 after buying an additional 20 shares during the last quarter. 73.85% of the stock is owned by institutional investors.

Shares of Colgate-Palmolive Company (CL) traded down 0.18% on Friday, reaching $71.42. The company’s stock had a trading volume of 559,387 shares. Colgate-Palmolive Company has a 12 month low of $63.43 and a 12 month high of $77.27. The stock has a market cap of $62.91 billion, a P/E ratio of 26.54 and a beta of 0.80. The firm’s 50-day moving average price is $72.96 and its 200-day moving average price is $72.71.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.72. The company had revenue of $3.83 billion for the quarter, compared to analysts’ expectations of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. Colgate-Palmolive’s revenue for the quarter was down .5% compared to the same quarter last year. During the same period last year, the firm posted $0.70 EPS. On average, analysts forecast that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 15th. Investors of record on Tuesday, July 18th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, July 14th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.24%. Colgate-Palmolive’s dividend payout ratio is 59.48%.

ILLEGAL ACTIVITY WARNING: “Brown Advisory Securities LLC Acquires 1,095 Shares of Colgate-Palmolive Company (NYSE:CL)” was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/08/11/brown-advisory-securities-llc-acquires-1095-shares-of-colgate-palmolive-company-nysecl.html.

A number of equities research analysts have recently issued reports on CL shares. Jefferies Group LLC started coverage on shares of Colgate-Palmolive in a research report on Tuesday, April 18th. They issued a “hold” rating and a $78.00 target price for the company. Royal Bank Of Canada reissued a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a research report on Monday, April 24th. UBS AG reissued a “neutral” rating and issued a $78.00 target price (down previously from $79.00) on shares of Colgate-Palmolive in a research report on Tuesday, May 2nd. Zacks Investment Research cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Wednesday, May 3rd. Finally, Vetr cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 target price for the company. in a research report on Wednesday, May 17th. Two equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $75.82.

In related news, COO Justin Skala sold 74,374 shares of the firm’s stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $72.51, for a total transaction of $5,392,858.74. Following the transaction, the chief operating officer now directly owns 97,177 shares of the company’s stock, valued at approximately $7,046,304.27. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Dennis J. Hickey sold 73,872 shares of the firm’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $71.80, for a total value of $5,304,009.60. Following the transaction, the chief financial officer now directly owns 484,985 shares in the company, valued at $34,821,923. The disclosure for this sale can be found here. Over the last three months, insiders have sold 203,969 shares of company stock worth $14,711,068. 1.02% of the stock is currently owned by insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.